A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Conditions
Secondary Progressive Multiple Sclerosis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Arizona Neuroscience Research, LLC, Phoenix, Arizona, United States
Perseverance Research Center, LLC (PRC), Scottsdale, Arizona, United States
Fullerton Neurology and Headache Center, Fullerton, California, United States
Regina Berkovich MD, PhD Inc, West Hollywood, California, United States
SFM Clinical Research, LLC, Boca Raton, Florida, United States
Nova Clinical Research, LLC, Bradenton, Florida, United States
MS and Neuromuscular Center of Excellence, Clearwater, Florida, United States
Neurology Associates, Maitland, Florida, United States
Josephson Wallack Munshower Neurology, Pc Suite 225, Indianapolis, Indiana, United States
KC Research Center, PA Neurology Research Dept, Roeland Park, Kansas, United States
Boston Clinical Trials, Boston, Massachusetts, United States
Profound Research LLC at Oakland Neurology Center, Rochester Hills, Michigan, United States
Washington University School of Medicine, St Louis, Missouri, United States
The Boster Center for Multiple Sclerosis, Columbus, Ohio, United States
OMRF Multiple Sclerosis Center of Excellence, Oklahoma City, Oklahoma, United States
Premier Neurology, Greenville, South Carolina, United States
Lone Star Neurology, San Antonio, Texas, United States
Texas Institute for Neurological Disorders - Sherman, Sherman, Texas, United States